JAMA: 2011-12-07, Vol. 306, No. 21, Author Interview
Interview with Waldemar A. Carlo, MD, author of Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation
Conclusions. Liposomal delivery of prednisolone improved renal bio-availability, increased perfusion and reduced cellular infiltrate in the allograft, when compared with conventional prednisolone. Clinical studies should reveal if treatment with LP results in improved efficacy and reduced side effects in patients with renal allograft rejection.
Modern regimen using corticosteroids (CS), tacrolimus and MMF reduced acute rejection rates after heart transplantation (HTx), but has not translated into improved long-term outcomes, potentially due to the complications of the drugs themselves. Therefore, many centers have tried to avoid or minimize CS, and in 2010 we adopted a weaning protocol, changing from a high dose CS regimen (1 mg/kg/day declining in the first month), to a low dose approach (prednisone 20 mg daily on day 3 with weaning within 9 months).
A large number of heart transplant patients are weaned off corticosteroids within the first year after heart transplantation. These patients are selected as they do not have rejection or graft dysfunction. In addition, these patients have not developed donor-specific antibodies (DSAs) and therefore are viewed as being immune-privileged. However, it has not been well established whether these patients have enhanced 5-year outcome compared to patients who remain on prednisone.
The development of donor specific antibody (DSA) after heart transplantation has been associated with increased development of cardiac allograft vasculopathy (CAV). Steroid weaning has been popular among heart transplant programs, however, it is not known whether steroid free regimens present an increased risk of the development of DSA. Therefore, we sought to address this question.
This study aimed to evaluate the long-term effects of the first-line immunotherapies on relapse and disability, and identify the prognostic predictors in NMOSD.MethodsIn this prospective cohort study, we enrolled patients with NMOSD from Southwest China and performed a long-term follow-up. We compared no immunotherapies (NIT) versus treatment of mycophenolate mofetil (MMF), azathioprine (AZA), or only corticosteroid (CS). Cox proportional-hazards model was used to explore the prognostic predictors in NMOSD.ResultsUltimately, 281 patients were enrolled during 2009 to 2017. The proportions of relapse, motor disability, and m...
The objective of this study was to evaluate the efficacy of rescue fractional microablative CO2 laser treatment in women with severe symptoms and sexual dysfunction related to lichen sclerosus not responsive to long-term ultra-potent topical corticosteroid treatment. Methods: Consecutive eligible women with lichen sclerosus referred to our unit who received fractional microablative CO2 laser treatment after failure of ultra-potent topical corticosteroid treatment were enrolled in the study. The diagnosis was confirmed by histological assessment in all cases. Patients underwent two cycles of CO2 laser every 30 to 40 days...
Publication date: Available online 31 March 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Suvina Amin, Mena Soliman, Andrew McIvor, Andrew Cave, Claudia Cabrera
We present a case of a 51 ‐year‐old Japanese woman diagnosed with eosinophilic granulomatous polyangiitis (EGPA), a rare vasculitis that can occur in patients with eosinophilia and history of asthma, allergic rhinitis, and sinusitis, with immunoglobulin (Ig) G4 hypergammaglobulinaemia and salivary gland swelling. AbstractA 51 ‐year‐old woman was admitted to our hospital for cough, fever, purpura in the legs, and salivary gland swelling. Six years ago, she had been diagnosed with bronchial asthma and was treated with a combination of inhaled corticosteroid and long‐acting beta2‐agonist. Blood examination showed ...